Home/Filings/4/0001104659-19-061301
4//SEC Filing

HealthQuest Partners II, L.P. 4

Accession 0001104659-19-061301

CIK 0001409269other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 9:56 PM ET

Size

13.9 KB

Accession

0001104659-19-061301

Insider Transaction Report

Form 4
Period: 2019-11-07
Transactions
  • Award

    Common Stock

    2019-11-07$3.75/sh+1,333,333$4,999,9993,995,621 total
  • Award

    Common Stock

    2019-11-07+1,567,4741,567,474 total
  • Award

    Common Stock

    2019-11-07+1,094,8142,662,288 total
  • Award

    Warrants (right to buy)

    2019-11-07+1,333,3331,333,333 total
    Exercise: $6.00From: 2020-05-07Exp: 2024-11-07Common Stock (666,666.5 underlying)
Transactions
  • Award

    Common Stock

    2019-11-07+1,567,4741,567,474 total
  • Award

    Common Stock

    2019-11-07+1,094,8142,662,288 total
  • Award

    Common Stock

    2019-11-07$3.75/sh+1,333,333$4,999,9993,995,621 total
  • Award

    Warrants (right to buy)

    2019-11-07+1,333,3331,333,333 total
    Exercise: $6.00From: 2020-05-07Exp: 2024-11-07Common Stock (666,666.5 underlying)
Footnotes (4)
  • [F1]Received, in connection with the merger of a wholly-owned subsidiary of Restoration Robotics, Inc. with and into Venus Concept Ltd. (the "Merger"), in exchange for 2,272,548 shares, 98,807 shares and 346,620 shares of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock of Venus Concept Ltd., respectively.
  • [F2]Held by HealthQuest Partners II, L.P. ("HealthQuest"). HealthQuest Venture Management II, L.L.C. ("HQVM II"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM II disclaim beneficial ownership of all shares held by HealthQuest except to the extent of any pecuniary interests therein.
  • [F3]Received in connection with the Merger, upon the conversion of the outstanding principal and any accrued and unpaid interest of three 8% Convertible Promissory Notes issued by Venus Concept Ltd., dated as of June 25, 2019, August 14, 2019 and August 21,2019, in the orignal principal amounts of $2,500,000, $985,714.24 and $4,014,285.76, respectively.
  • [F4]These securities were purchased from the Issuer at a purchase price of $3.75 per unit, consisting of one share of Common Stock and a warrant exercisable for 0.5 shares of Common Stock, with two warrants exercisable for one share of Common Stock at an exercise price of $6.00 per share.

Issuer

Venus Concept Inc.

CIK 0001409269

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001660910

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 9:56 PM ET
Size
13.9 KB